Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 78 articles: HTML format

Single Articles

May 2024
1. KAWAGUCHI H
   Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study'.
   J Clin Endocrinol Metab. 2024 May 18:dgae347. doi: 10.1210.
   PubMed    
   
   
   
2. FARR JN
   Cardiovascular Safety and Romosozumab - The Plot Thickens.
   J Clin Endocrinol Metab. 2024 May 8:dgae313. doi: 10.1210.
   PubMed    
   
   
   April 2024
3. KAJIKAWA M, Maruhashi T, Kishimoto S, Yamaji T, et al
   A Body Shape Index as a Simple Anthropometric Marker of Abdominal Obesity and Risk of Cardiovascular Events.
   J Clin Endocrinol Metab. 2024 Apr 25:dgae282. doi: 10.1210.
   PubMed     Abstract available
   
   
   
4. ZHANG G, Jiang W, He F, Fu J, et al
   LDL-C and TC mediate the risk of PNPLA3 inhibition on cardiovascular diseases.
   J Clin Endocrinol Metab. 2024 Apr 18:dgae264. doi: 10.1210.
   PubMed     Abstract available
   
   
   
5. CHE J, He N, Kuang X, Zheng C, et al
   Dietary n-3 fatty acids intake and all-cause and cardiovascular mortality in patients with pre-diabetes and diabetes.
   J Clin Endocrinol Metab. 2024 Apr 16:dgae265. doi: 10.1210.
   PubMed     Abstract available
   
   
   
6. SONG X, Xiong L, Guo T, Chen X, et al
   Cystatin C is a predictor for long-term All-Cause and Cardiovascular Mortality in US Adults with Metabolic Syndrome.
   J Clin Endocrinol Metab. 2024 Apr 10:dgae225. doi: 10.1210.
   PubMed     Abstract available
   
   
   March 2024
7. QIU Z, Lee DH, Lu Q, Li R, et al
   Associations of Regional Body Fat with Risk of Cardiovascular Disease and Mortality among Individuals with Type 2 Diabetes.
   J Clin Endocrinol Metab. 2024 Mar 26:dgae192. doi: 10.1210.
   PubMed     Abstract available
   
   
   
8. VAN DER VALK ES, Mohseni M, Iyer AM, van den Hurk M, et al
   Long-term glucocorticoid exposure and incident cardiovascular diseases - the Lifelines cohort.
   J Clin Endocrinol Metab. 2024 Mar 19:dgae081. doi: 10.1210.
   PubMed     Abstract available
   
   
   
9. STOKAR J, Szalat A
   Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study.
   J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210.
   PubMed     Abstract available
   
   
   
10. COSTA FC, Gomes LG, de Lima TM, Bortolotto LA, et al
    Cardiovascular risk in women with nonclassical congenital adrenal hyperplasia.
    J Clin Endocrinol Metab. 2024 Mar 11:dgae155. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2024
11. CHEN GC, Hukportie DN, Liu YJ, Wang HP, et al
    Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae100. doi: 10.1210.
    PubMed     Abstract available
    
    
    
12. KIM MK, Lee KN, Han K, Lee SH, et al
    Diabetes duration, cholesterol levels, and risk of cardiovascular diseases in individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Feb 15:dgae092. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2024
13. ZHU K, Geng T, Qiu Z, Li R, et al
    Beverage Consumption, Genetic Predisposition, and Risk of Cardiovascular Disease among Adults with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jan 27:dgae050. doi: 10.1210.
    PubMed     Abstract available
    
    
    
14. 
    Correction to: "Childhood Obesity, Diabetes, and Cardiovascular Disease Risk".
    J Clin Endocrinol Metab. 2024 Jan 20:dgae030. doi: 10.1210.
    PubMed    
    
    
    December 2023
15. QIN Z, Muhanhali D, Ling Y
    Impaired thyroid hormone sensitivity increases risk of cardiovascular events in patients undergoing coronary angiography.
    J Clin Endocrinol Metab. 2023 Dec 16:dgad735. doi: 10.1210.
    PubMed     Abstract available
    
    
    
16. 
    Correction to: "Long-term Cardiovascular Disease After Adverse Pregnancy Outcomes".
    J Clin Endocrinol Metab. 2023 Dec 6:dgad692. doi: 10.1210.
    PubMed    
    
    
    
17. 
    Correction to: "Reassuring Data on the Cardiovascular Risk in Adults With X-linked Hypophosphatemia Receiving Conventional Therapy".
    J Clin Endocrinol Metab. 2023 Dec 6:dgad703. doi: 10.1210.
    PubMed    
    
    
    November 2023
18. BANCKS MP, Pilla SJ, Balasubramanyam A, Yeh HC, et al
    Association of lifestyle intervention with risk for cardiovascular events differs by level of glycated hemoglobin.
    J Clin Endocrinol Metab. 2023 Nov 18:dgad674. doi: 10.1210.
    PubMed     Abstract available
    
    
    
19. CHEN AX, Radhakutty A, Drake SM, Kiu A, et al
    Cardiovascular risk markers in adults with adrenal incidentaloma and mild autonomous cortisol secretion.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad665. doi: 10.1210.
    PubMed     Abstract available
    
    
    
20. 
    Correction to "Association of Circulating Very Long-Chain Saturated Fatty Acids With Cardiovascular Mortality in NHANES 2015 to 2016".
    J Clin Endocrinol Metab. 2023 Nov 2:dgad633. doi: 10.1210.
    PubMed    
    
    
    
21. ROSENBERG EA, Seely EW
    Long-term Cardiovascular Disease After Adverse Pregnancy Outcomes.
    J Clin Endocrinol Metab. 2023 Nov 2:dgad600. doi: 10.1210.
    PubMed     Abstract available
    
    
    
22. YE J, Li K
    Letter to the Editor from Ye and Li: "Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016".
    J Clin Endocrinol Metab. 2023 Nov 1:dgad647. doi: 10.1210.
    PubMed    
    
    
    October 2023
23. ZENG C, Liu M, Zhang Y, Deng S, et al
    Association of Urine Albumin-to-Creatinine Ratio with Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad645. doi: 10.1210.
    PubMed     Abstract available
    
    
    
24. HIRSCHBERG AL
    Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
    J Clin Endocrinol Metab. 2023 Oct 27:dgad590. doi: 10.1210.
    PubMed     Abstract available
    
    
    
25. PENNA GC, Bianco AC, Ettleson MD
    A cross-sectional analysis of cardiovascular and bone healthcare utilization during treatment with thyroid hormone.
    J Clin Endocrinol Metab. 2023 Oct 25:dgad629. doi: 10.1210.
    PubMed     Abstract available
    
    
    
26. CHAROENSRI S, Auchus RJ
    Predictors of cardiovascular morbidities in adults with 21-hydroxylase deficiency congenital adrenal hyperplasia.
    J Clin Endocrinol Metab. 2023 Oct 25:dgad628. doi: 10.1210.
    PubMed     Abstract available
    
    
    
27. BROOME DT
    SGLT-2 Inhibitors: Discrepancy Between MACE Reduction and Incident MI and Stroke.
    J Clin Endocrinol Metab. 2023;108:e1450-e1451.
    PubMed    
    
    
    
28. BOUZEMANE A, Vignot E, Dubourg LD, De Mul A, et al
    Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy.
    J Clin Endocrinol Metab. 2023 Oct 16:dgad608. doi: 10.1210.
    PubMed     Abstract available
    
    
    September 2023
29. TAO X, Liu L, Ma P, Hu J, et al
    Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016.
    J Clin Endocrinol Metab. 2023 Sep 21:dgad561. doi: 10.1210.
    PubMed     Abstract available
    
    
    
30. ANAWALT BD
    TRAVERSING the Mountain of Ignorance: Testosterone and Cardiovascular Safety.
    J Clin Endocrinol Metab. 2023 Sep 21:dgad555. doi: 10.1210.
    PubMed    
    
    
    
31. SOUTH AM, Rigdon J, Voruganti S, Stafford JM, et al
    Uric Acid is Not Associated with Cardiovascular Health in Youth with Type 1 Diabetes: SEARCH for Diabetes in Youth Study.
    J Clin Endocrinol Metab. 2023 Sep 10:dgad534. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2023
32. SHUFELT CL, Saadedine M, Cook-Wiens G, Pisarska MD, et al
    Functional Hypothalamic Amenorrhea and Preclinical Cardiovascular Disease.
    J Clin Endocrinol Metab. 2023 Aug 23:dgad498. doi: 10.1210.
    PubMed     Abstract available
    
    
    
33. CHEN Z, Liu M, Xu X, He L, et al
    Serum klotho modifies the associations of 25-hydroxy vitamin D with all-cause and cardiovascular mortality.
    J Clin Endocrinol Metab. 2023 Aug 15:dgad480. doi: 10.1210.
    PubMed     Abstract available
    
    
    
34. YUAN D, Xu N, Song Y, Zhang Z, et al
    Association Between Free Fatty Acids and Cardiometabolic Risk in Coronary Artery Disease: Results From the PROMISE Study.
    J Clin Endocrinol Metab. 2023 Aug 4:dgad416. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2023
35. RAZAVI AC, Jain V, Grandhi GR, Patel P, et al
    Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?
    J Clin Endocrinol Metab. 2023 Jul 12:dgad406. doi: 10.1210.
    PubMed     Abstract available
    
    
    
36. GURGOGLIONE FL, Pitocco D, Montone RA, Rinaldi R, et al
    Microvascular complications are associated with coronary collateralization in type 2 diabetes and chronic occlusion.
    J Clin Endocrinol Metab. 2023 Jul 7:dgad396. doi: 10.1210.
    PubMed     Abstract available
    
    
    
37. YE B, Zhao Q, Fan J, Li X, et al
    RBP4-based multimarker score: A prognostic tool for adverse cardiovascular events in acute coronary syndrome patients.
    J Clin Endocrinol Metab. 2023 Jul 4:dgad389. doi: 10.1210.
    PubMed     Abstract available
    
    
    
38. LOPEZ DS, Mulla JS, El Haddad D, Tahashilder MI, et al
    Testosterone replacement therapy in relation with cardiovascular disease in cisgender women and transgender people.
    J Clin Endocrinol Metab. 2023 Jul 1:dgad388. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2023
39. SALAMA M, Balagopal B, Fennoy I, Kumar S, et al
    Childhood Obesity, Diabetes and Cardiovascular Disease Risk.
    J Clin Endocrinol Metab. 2023 Jun 16:dgad361. doi: 10.1210.
    PubMed     Abstract available
    
    
    
40. OHLSSON C, Nethander M, Norlen AK, Poutanen M, et al
    Serum DHEA and Testosterone Levels Associate Inversely with Coronary Artery Calcification in Elderly Men.
    J Clin Endocrinol Metab. 2023 Jun 12:dgad351. doi: 10.1210.
    PubMed     Abstract available
    
    
    
41. LIN X, Chen X, Liu S, Deng Y, et al
    Associations of Serum 25(OH)D with Risk of Recurrent Cardiovascular Events in Individuals with Coronary Heart Disease.
    J Clin Endocrinol Metab. 2023 Jun 6:dgad339. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2023
42. SU S, Fan J, Yang Y, Yang C, et al
    Birth weight, cardiometabolic factors and coronary heart disease: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2023 May 29:dgad308. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2023
43. LANG X, Zhao B, Fang S, Li L, et al
    Higher peripheral thyroid sensitivity is linked to a lower risk of heart failure after acute myocardial infarction.
    J Clin Endocrinol Metab. 2023 Apr 27:dgad240. doi: 10.1210.
    PubMed     Abstract available
    
    
    
44. WANG C, Xin Q, Zheng M, Liu S, et al
    Association of Resting Heart Rate Trajectories with Cardiovascular Disease and Mortality in Diabetes Mellitus Patients.
    J Clin Endocrinol Metab. 2023 Apr 21:dgad228. doi: 10.1210.
    PubMed     Abstract available
    
    
    
45. MUKAMA T, Srour B, Johnson T, Katzke V, et al
    IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all-causes in EPIC - Heidelberg.
    J Clin Endocrinol Metab. 2023 Apr 17:dgad212. doi: 10.1210.
    PubMed     Abstract available
    
    
    
46. PEI J, Liu C, Yang Z, Lai Y, et al
    Association of KATP Variants With CMD and RAP in CAD Patients With Increased Serum Lipoprotein(a) Levels.
    J Clin Endocrinol Metab. 2023;108:1061-1074.
    PubMed     Abstract available
    
    
    March 2023
47. DEI CAS A, Aldigeri R, Mantovani A, Masulli M, et al
    Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Mar 7:dgad127. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2023
48. MUKHOPADHYAY P, Sanyal D, Chatterjee P, Pandit K, et al
    SGLT2 inhibitors: Effect on myocardial infarction and stroke in type 2 diabetes.
    J Clin Endocrinol Metab. 2023 Feb 28:dgad113. doi: 10.1210.
    PubMed     Abstract available
    
    
    
49. HU T, Shen Y, Cao W, Xu Y, et al
    The association and joint effect of adipocyte fatty acid-binding protein and obesity phenotype with cardiovascular events.
    J Clin Endocrinol Metab. 2023 Feb 27:dgad110. doi: 10.1210.
    PubMed     Abstract available
    
    
    
50. LIN J, Yang L, Huang J, Liu Y, et al
    Insulin-like Growth Factor 1 and Risk of Cardiovascular Disease: Results from the UK Biobank Cohort Study.
    J Clin Endocrinol Metab. 2023 Feb 22:dgad105. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2023
51. HORTON WB, Snell-Bergeon JK
    HbA1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: the CACTI Study.
    J Clin Endocrinol Metab. 2023 Jan 13:dgad019. doi: 10.1210.
    PubMed     Abstract available
    
    
    December 2022
52. GENG T, Chen JX, Zhou YF, Lu Q, et al
    Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2022 Dec 27:dgac750. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2022
53. BLIUC D, Tran T, Chen W, Alarkawi D, et al
    Anti-resorptive medication use is not associated with acute cardiovascular risk: An observational study: Anti-resorptive medication and cardiovascular risk.
    J Clin Endocrinol Metab. 2022 Nov 21:dgac669. doi: 10.1210.
    PubMed     Abstract available
    
    
    
54. YE C, Kong L, Wang Y, Lin H, et al
    Causal associations between age at diagnosis of diabetes and cardiovascular outcomes: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Nov 14. pii: 6825732. doi: 10.1210.
    PubMed     Abstract available
    
    
    
55. BHADADA SK, Malhotra B, Shetty AJ
    Body weight variability and cardiovascular health in diabetes.
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785762. doi: 10.1210.
    PubMed    
    
    
    October 2022
56. 
    Correction to "New Horizons: Revival of Lipoprotein (a) as a Risk Factor for Cardiovascular Disease".
    J Clin Endocrinol Metab. 2022 Oct 20. pii: 6764776. doi: 10.1210.
    PubMed    
    
    
    September 2022
57. WU VC, Peng KY, Hu YH, Chang CC, et al
    Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes.
    J Clin Endocrinol Metab. 2022 Sep 19. pii: 6705062. doi: 10.1210.
    PubMed     Abstract available
    
    
    
58. NESTEL P, Loh WJ, Ward NC, Watts GF, et al
    New Horizons: Revival of Lipoprotein (a) as a risk factor for cardiovascular disease.
    J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701631. doi: 10.1210.
    PubMed     Abstract available
    
    
    
59. 
    Correction to: "Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes".
    J Clin Endocrinol Metab. 2022 Sep 14. pii: 6698734. doi: 10.1210.
    PubMed    
    
    
    
60. LI Y, Gao R, Zhao B, Zhang Y, et al
    Low serum bicarbonate levels increased the risk of all-cause, cardiovascular and cancer Mortality in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Sep 6. pii: 6692819. doi: 10.1210.
    PubMed     Abstract available
    
    
    
61. WEI H, Zhao M, Wu J, Li C, et al
    Association of Systemic Trimethyllysine with Heart Failure with Preserved Ejection Fraction and Cardiovascular Events.
    J Clin Endocrinol Metab. 2022 Sep 5. pii: 6691858. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2022
62. DONG Y, Chen Z, Gong Y, Han Y, et al
    The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis (jc.2022-01089).
    J Clin Endocrinol Metab. 2022 Aug 16. pii: 6666536. doi: 10.1210.
    PubMed     Abstract available
    
    
    
63. DONG Y, Chen Z, Gong Y, Han Y, et al
    The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis.
    J Clin Endocrinol Metab. 2022 Aug 15. pii: 6666536. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2022
64. HOU T, Li M, Lin H, Zhao Z, et al
    The causal effect of systolic blood pressure lowering on vascular outcomes in diabetes: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Jun 15. pii: 6608757. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2022
65. CHOI HR, Chang Y, Kim Y, Cho Y, et al
    Ideal cardiovascular health metrics and risk of incident early-onset vasomotor symptoms among premenopausal women.
    J Clin Endocrinol Metab. 2022 May 21. pii: 6590294. doi: 10.1210.
    PubMed     Abstract available
    
    
    
66. LETO G, Tartaglione L, Rotondi S, Pasquali M, et al
    Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease.
    J Clin Endocrinol Metab. 2022 May 20. pii: 6590071. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2022
67. CUKIERMAN-YAFFE T, Gerstein HC, Basile J, Bethel MA, et al
    Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6569991. doi: 10.1210.
    PubMed     Abstract available
    
    
    
68. SUZUKI Y, Kaneko H, Okada A, Matsuoka S, et al
    Prediabetes in Young Adults and Its Association with Cardiovascular Health Metrics in the Progression to Diabetes.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6572042. doi: 10.1210.
    PubMed     Abstract available
    
    
    
69. DENG X, Zhang C, Wang P, Wei W, et al
    Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565990. doi: 10.1210.
    PubMed     Abstract available
    
    
    March 2022
70. DAM V, Onland-Moret NC, Burgess S, Chirlaque MD, et al
    Genetically determined reproductive aging and coronary heart disease: a bidirectional two-sample Mendelian Randomization.
    J Clin Endocrinol Metab. 2022 Mar 20. pii: 6550950. doi: 10.1210.
    PubMed     Abstract available
    
    
    
71. NASR A, Matthews K, Janssen I, Brooks MM, et al
    Associations of abdominal and cardiovascular adipose tissue depots with HDL metrics in midlife women: The SWAN Study.
    J Clin Endocrinol Metab. 2022 Mar 17. pii: 6550277. doi: 10.1210.
    PubMed     Abstract available
    
    
    
72. JIANG W, Song Q, Zhang J, Chen Y, et al
    The Association of Consumption Time for Food With Cardiovascular Disease and All-Cause Mortality Among Diabetic Patients.
    J Clin Endocrinol Metab. 2022 Mar 15. pii: 6546321. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2022
73. CHEN D, Zhang Y, Yidilisi A, Xu Y, et al
    Causal associations between circulating adipokines and cardiovascular disease: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Feb 3. pii: 6521299. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2021
74. YANG J, Zheng Y, Li C, Liu YP, et al
    The impact of subclinical hyperthyroidism on cardiovascular prognosis in patients undergoing PCI.
    J Clin Endocrinol Metab. 2021 Nov 29. pii: 6446179. doi: 10.1210.
    PubMed     Abstract available
    
    
    
75. SRINIVASA S, Thomas TS, Feldpausch MN, Adler GK, et al
    Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights From the Renin-Angiotensin-Aldosterone System.
    J Clin Endocrinol Metab. 2021;106:3398-3412.
    PubMed     Abstract available
    
    
    
76. SAATMANN N, Zaharia OP, Strassburger K, Pesta DH, et al
    Physical fitness and cardiovascular risk factors in the novel diabetes subgroups.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423502. doi: 10.1210.
    PubMed     Abstract available
    
    
    
77. ZUO Y, Han X, Tian X, Chen S, et al
    Association of Impaired Fasting Glucose with Cardiovascular Disease in the Absence of Risk Factor.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423498. doi: 10.1210.
    PubMed     Abstract available
    
    
    October 2021
78. HONG S, Park JH, Han K, Lee CB, et al
    Association between Obesity and Cardiovascular Disease in Elderly Patients with Diabetes: A Retrospective Cohort Study.
    J Clin Endocrinol Metab. 2021 Oct 1. pii: 6379050. doi: 10.1210.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.